Adverse effects following intravenous fluid therapy in the horse using non-commercial fluids: preliminary findings.
Non-commercial, endotoxin positive, intravenous fluids as well as a commercially available intravenous fluid were given to clinically normal horses. Endotoxin-positive fluids caused clinical signs attributable to endotoxaemia. Leukopenia, preceded by a fluctuating white cell count, was observed in horses showing clinical signs. The commercial intravenous fluid had no effect on the white cell count or on the clinical state. Precautions to be taken and recommendations are made with regard to the monitoring of horses in which one might be forced to use non-commercial intravenous fluids.